ATE63810T1 - Nicardipin-hydrochlorid-injektionsloesungen sowie deren herstellung. - Google Patents

Nicardipin-hydrochlorid-injektionsloesungen sowie deren herstellung.

Info

Publication number
ATE63810T1
ATE63810T1 AT85303588T AT85303588T ATE63810T1 AT E63810 T1 ATE63810 T1 AT E63810T1 AT 85303588 T AT85303588 T AT 85303588T AT 85303588 T AT85303588 T AT 85303588T AT E63810 T1 ATE63810 T1 AT E63810T1
Authority
AT
Austria
Prior art keywords
preparation
nicardipine hydrochloride
injection solutions
hydrochloride injection
nicardipine
Prior art date
Application number
AT85303588T
Other languages
English (en)
Inventor
Ogawa Katayasu
Go Ohtani
Shoji Yokota
Masayoshi Aruga
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of ATE63810T1 publication Critical patent/ATE63810T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT85303588T 1984-05-22 1985-05-21 Nicardipin-hydrochlorid-injektionsloesungen sowie deren herstellung. ATE63810T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59102991A JPS60246313A (ja) 1984-05-22 1984-05-22 塩酸ニカルジピンの注射剤およびその製法
EP85303588A EP0162705B1 (de) 1984-05-22 1985-05-21 Nicardipin-Hydrochlorid-Injektionslösungen sowie deren Herstellung

Publications (1)

Publication Number Publication Date
ATE63810T1 true ATE63810T1 (de) 1991-06-15

Family

ID=14342164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85303588T ATE63810T1 (de) 1984-05-22 1985-05-21 Nicardipin-hydrochlorid-injektionsloesungen sowie deren herstellung.

Country Status (11)

Country Link
US (1) US4880823A (de)
EP (1) EP0162705B1 (de)
JP (1) JPS60246313A (de)
KR (1) KR910003555B1 (de)
AT (1) ATE63810T1 (de)
CA (1) CA1240930A (de)
DE (1) DE3582954D1 (de)
ES (1) ES8700567A1 (de)
GR (1) GR851230B (de)
MX (1) MX9203588A (de)
PT (1) PT80486B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8617482D0 (en) * 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
JPH0696533B2 (ja) * 1987-01-14 1994-11-30 北陸製薬株式会社 キノロンカルボン酸の水性組成物
YU45837B (sh) * 1988-01-18 1992-07-20 LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom
BE1003647A5 (fr) * 1989-02-28 1992-05-12 Syntex Inc Composition pharmaceutique de nicardipine pour administration parenterale.
WO1998001138A1 (fr) * 1996-07-04 1998-01-15 Nippon Kayaku Kabushiki Kaisha Injections de succinate sodique de methylprednisolone
US20070112041A1 (en) * 2005-11-16 2007-05-17 Sun Pharmaceutical Industries Limited Nicardipine injection composition
CA2650922C (en) 2006-04-18 2015-09-29 Ekr Therapeutics, Inc. Pre-mixed, ready-to-use pharmaceutical compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3720761A (en) * 1968-10-14 1973-03-13 W Hunter Injectable radio-pharmaceutical scanning agent and preparation
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3023495C2 (de) * 1980-06-24 1982-04-08 Kienzle Apparate Gmbh, 7730 Villingen-Schwenningen Diagrammauswertegerät für die Unfalldiagrammauswertung von Fahrtschreiber-Diagrammen
JPS57167967A (en) * 1981-04-08 1982-10-16 Yoshitomi Pharmaceut Ind Ltd 1,4-dihydropyridine-3,5-dicarboxylic acid ester or its salt
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
JPS58172312A (ja) * 1982-04-02 1983-10-11 Toa Eiyou Kagaku Kogyo Kk ニフエジピン外用剤
DE3212736A1 (de) * 1982-04-06 1983-10-13 Bayer Ag, 5090 Leverkusen Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
JPS597163A (ja) * 1982-07-02 1984-01-14 Yamanouchi Pharmaceut Co Ltd 抗動脈硬化剤
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
DE3316510A1 (de) * 1983-05-06 1984-11-08 Bayer Ag Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen
JPS6016917A (ja) * 1983-07-08 1985-01-28 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンまたはニフエジピンの軟膏剤

Also Published As

Publication number Publication date
PT80486A (en) 1985-06-01
CA1240930A (en) 1988-08-23
ES8700567A1 (es) 1986-10-16
US4880823A (en) 1989-11-14
KR850008278A (ko) 1985-12-16
ES543343A0 (es) 1986-10-16
EP0162705B1 (de) 1991-05-29
EP0162705A2 (de) 1985-11-27
MX9203588A (es) 1992-07-31
JPS60246313A (ja) 1985-12-06
EP0162705A3 (en) 1987-01-28
PT80486B (en) 1986-12-12
DE3582954D1 (de) 1991-07-04
GR851230B (de) 1985-11-25
JPH0247964B2 (de) 1990-10-23
KR910003555B1 (ko) 1991-06-05

Similar Documents

Publication Publication Date Title
IT8847884A0 (it) Elettrodo enzimatico e modulo di elettrodo nonche' relativo metodo di impiego
DK0486499T3 (da) Stabile sammensætninger af ascorbinsyre
ATE41307T1 (de) Waessrige, eine fettloesliche wirksubstanz enthaltende loesung sowie verfahren zu deren herstellung.
IT8567165A1 (it) Composizioni a base di liposomi, particolarmente per mantenere ed immobilizzare una riserva di agenti biologicamente attivi, e relativo procedimento d'impiego.
FI845004A0 (fi) Munskoeljningsloesning.
DK57585A (da) Tandrensetablet med antiplaquevirkning
ATE63810T1 (de) Nicardipin-hydrochlorid-injektionsloesungen sowie deren herstellung.
DE69002697D1 (de) Carboplatinzusammensetzung.
IT8520085A0 (it) Tenuta per stato di inattivita'.
ATE47518T1 (de) Injizierbare pharmazeutische zusammenstellungen die bestaendige 5-adenosyl-l-methionin-salze enthalten.
ATE76080T1 (de) Biologisch aktive fluoreszierende zyklische nukleotide.
ATE84220T1 (de) Injektionszusammensetzung, die modifiziertes tpa enthaelt.
ATE60903T1 (de) Stabile, waessrige vincristinsulfatloesung.
IT1190399B (it) Processo per la preparazione di composti carbonilici otticamente attivi
BG60542B2 (en) Water soluble composition having coccidiostatic effect
FR2558468B1 (fr) Derives de l'acide b-(4-isocyano-1,2,3,4- diepoxycyclopentyl) acrylique et compositions, notamment pharmaceutiques, les contenant
KR850005777A (ko) 신포접화합물의 제조방법
ATA298685A (de) Verfahren zur herstellung lagerstabiler konzentrierter waessriger loesungen von melaminformaldehydkondensaten, sowie deren verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time